Breast Cancer Bio-Marker Gears Doctors Toward Better Treatment
Some recent scientific research has made the remarkable discovery of a bio-marker for breast cancer. This molecule acts as an indicator of a particularly aggressive form of breast cancer known as BLBC, allowing doctors to treat the disease before it has time to propagate. By acting quickly and treating tumors before they can even begin to start growing, doctors should be able to cure many more patients and ultimately help to save a lot more lives. This discovery could be an important turning point in the long-lasting battle against one of the most fatal diseases mankind has ever seen.
BLBC is a particularly stubborn form of breast cancer which is effectively immune to the majority of treatment methods employed for other forms of cancer. It also has the ability to grow at a much faster rate than other varieties, making it one of the most difficult forms of cancer to treat. Therefore, patients with this type of cancer often struggle with extensive treatments and ineffective methods, but this new discovery could certainly give these people a chance for a brighter future.
The study itself was undertaken by scientists working at Boston University School of Medicine. While performing their research, scientists looked at different bio-markers on individual cancerous cells, comparing them to the markers on healthy cells. In their search for any signs or differences between the two types of cells, researchers came upon the presence of a marker known as interleukin-13 receptor alpha 2, known as IL13RA2 for short. This marker was found to be much more commonly present in cells with BLBC.
Incredibly, the researchers also discovered that the presence of this marker actually changed the rate of cancerous tumor growth. By decreasing the amount of IL13RA2 in the cells themselves and instead injecting it into tumors, the tumors would then begin to grow less quickly. By reducing the quantities of IL13RA2 in lung cancer cells, the spread of the disease was reduced. This could indicate that the presence of this marker in cancerous cells actually helps to encourage the spread of the disease, but more research is required to truly understand every aspect of this molecule.
One of the scientists working on this study, Associate Professor at Boston University School of Medicine Doctor Sam Thiagalingam, said that this discovery will hopefully be appreciated by people suffering from BLBC. Thiagalingam hopes that new and more effective treatment methods will be developed thanks to the results of this research. He said that scientists and doctors could now work on creating types of treatment which specifically target the presence of IL13RA2, eliminating it from a patient’s system in order to reduce the spread of cancer. The doctor believes that more research is evidently required into the effects and workings of this particular bio-marker, but he believes that more studies should be able to greatly help with treatment of this disease and save lives in the future.